The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 12, 2023

Filed:

Feb. 03, 2021
Applicants:

Neumora Therapeutics, Inc., Brisbane, CA (US);

Yale University, New Haven, CT (US);

Inventors:

John D. Murray, New Haven, CT (US);

Alan Anticevic, New Haven, CT (US);

William J. Martin, San Francisco, CA (US);

Assignee:

NEUMORA THERAPEUTICS, INC., Brisbane, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16B 20/00 (2019.01); G16H 20/10 (2018.01); G16B 40/00 (2019.01); G16H 30/20 (2018.01); G16H 50/20 (2018.01); G16B 25/10 (2019.01);
U.S. Cl.
CPC ...
G16B 20/00 (2019.02); G16B 25/10 (2019.02); G16B 40/00 (2019.02); G16H 20/10 (2018.01); G16H 50/20 (2018.01); G16H 30/20 (2018.01);
Abstract

The present tools and methods for detecting, diagnosing, predicting, prognosticating, or treating a neurobehavioral phenotype in a subject. These tools and methods relates to a genotype and neurophenotype topography-based approach for analyzing brain neuroimaging and gene expression maps to identify drug targets associated with neurobehavioral phenotypes and, conversely, neurobehavioral phenotypes associated with potential drug targets, to develop rational design and application of pharmacological therapeutics for brain disorders, and to provide methods and tools for treatment of subjects in need of neurological therapy.


Find Patent Forward Citations

Loading…